Finance

Lists
Why is AGIO down ၄.၀၃%?
Dive Deeper
AGIO:NASDAQ
Agios Pharmaceuticals Inc
၂၇.၆၀ US$
-၄.၀၃%
(-၁.၁၆) 1D
၂၇.၆၀ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AGIO...
Open
၂၈.၀၁ US$
High
၂၉.၁၄ US$
Low
၂၇.၄၃ US$
Mkt. cap
၁၆၅.၀၇ ဋေ
Avg. vol.
၁.၁၃ သန်း
Volume
၇.၇၆ သိန်း
52-wk high
၄၄.၀၇ US$
52-wk low
၂၃.၀၂ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
Open
၂၈.၀၁ US$
High
၂၉.၁၄ US$
Low
၂၇.၄၃ US$
Mkt. cap
၁၆၅.၀၇ ဋေ
Avg. vol.
၁.၁၃ သန်း
Volume
၇.၇၆ သိန်း
52-wk high
၄၄.၀၇ US$
52-wk low
၂၃.၀၂ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
News stories
From web sources and news partners
The Arkansas Democrat-Gazette
The Arkansas Democrat-Gazette
·
ပြီးခဲ့သည့် ၁ နာရီ
AI-led sell-off drags S&P 500 down by 3.7%
Traders Union
Traders Union
·
ပြီးခဲ့သည့် ၄ နာရီ
VIX fear index hits highest level since April 2025 as S&P 500 plunges
The Loadstar
The Loadstar
·
ပြီးခဲ့သည့် ၁ နာရီ
CNBC: S&P 500 and Dow close in correction; Nasdaq erases 2026 gain as AI rout picks up steam
Trefis
Trefis
·
ပြီးခဲ့သည့် ၂ နာရီ
25 S&P 500 Stocks Just Made New 52-Week Lows
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc
CEO-
Employees၅၄၀
Founded၂၀၀၈
Headquarters-
SectorHealth Care
Industry-
Websiteagios.com
Analyst ratings
Based on 6 analysts giving stock ratings to AGIO in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AGIO in the last 3 months.
Highest
Current ၂၇.၆၀ US$
၆၂.၀၀ US$ (+၁၂၄.၆၄%)
Average
၄၃.၁၇ US$ (+၅၆.၄၁%)
Lowest
၃၀.၀၀ US$ (+၈.၇၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tessa Romero
J.P. Morgan
Hold
Reiterated
၃၀.၀၀ US$
+၈.၇%
11/20/2026
Luca Issi
RBC Capital
Hold
Maintained
၃၂.၀၀ US$
+၁၅.၉%
11/05/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
၄၈.၀၀ US$
+၇၃.၉%
11/06/2026
Douglas Tsao
H.C. Wainwright
Buy
Maintained
၆၂.၀၀ US$
+၁၂၄.၆%
11/06/2026
Gregory Renza
Truist Financial
Buy
Maintained
၃၅.၀၀ US$
+၂၆.၈%
11/06/2026
Samantha Semenkow
Citi
Buy
Maintained
၅၂.၀၀ US$
+၈၈.၄%
10/28/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
08/03/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
၅၅.၀၀ US$
+၉၉.၃%
07/30/2026
Salveen Richter
Goldman Sachs
Hold
Maintained
၃၂.၀၀ US$
+၁၅.၉%
07/21/2026
Andrew Berens
Leerink Partners
Buy
Maintained
-
-
07/07/2026
Last report
၂၀၂၆ နို ၅
Fiscal period
Q3 2026
-၁.၀၉ US$ / -၁.၂၃ US$
+၁၁.၃၈%beat
Revenue / Est. (USD)
၅.၅၄ ကုဋေ / ၅.၁၆ ကုဋေ
+၇.၃၃%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၂.၀၀ ကုဋေ
၂.၀၇ ကုဋေ
၄.၄၇ ကုဋေ
၅.၅၄ ကုဋေ
Cost of goods sold
၈.၉၉ ကုဋေ
၈.၂၅ ကုဋေ
၁၀.၃၈ ကုဋေ
၇.၆၀ ကုဋေ
Cost of revenue
၈.၉၉ ကုဋေ
၈.၂၅ ကုဋေ
၁၀.၃၈ ကုဋေ
၇.၆၀ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅.၁၆ ကုဋေ
၄.၈၃ ကုဋေ
၅.၁၅ ကုဋေ
၅.၆၅ ကုဋေ
Operating expense
၅.၁၆ ကုဋေ
၄.၈၃ ကုဋေ
၅.၁၅ ကုဋေ
၅.၆၅ ကုဋေ
Total operating expenses
၁၄.၁၅ ကုဋေ
၁၃.၀၈ ကုဋေ
၁၅.၅၃ ကုဋေ
၁၃.၂၅ ကုဋေ
Operating income
-၁၂.၁၆ ကုဋေ
-၁၁.၀၀ ကုဋေ
-၁၁.၀၆ ကုဋေ
-၇.၇၂ ကုဋေ
Other non operating income
၁.၁၃ သိန်း
၁.၁၉ သိန်း
၁.၁၉ သိန်း
၃.၂၄ သန်း
EBT including unusual items
-၁၀.၉၁ ကုဋေ
-၉.၉၁ ကုဋေ
-၁၀.၀၇ ကုဋေ
-၆.၅၀ ကုဋေ
EBT excluding unusual items
-၁၀.၉၁ ကုဋေ
-၉.၉၁ ကုဋေ
-၁၀.၀၇ ကုဋေ
-၆.၅၀ ကုဋေ
Income tax expense
-၁.၀၂ သန်း
-
-
-
Effective tax rate
၀.၉၃%
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁၀.၈၀ ကုဋေ
-၉.၉၁ ကုဋေ
-၁၀.၀၇ ကုဋေ
-၆.၅၀ ကုဋေ
Net profit margin
-၅၄၁.၀၉%
-၄၇၇.၇၄%
-၂၂၅.၀၆%
-၁၁၇.၄၄%
Earnings per share
-၁.၈၅
-၁.၆၉
-၁.၆၉
-၁.၀၉
Interest and investment income
၁.၂၄ ကုဋေ
၁.၀၈ ကုဋေ
၉.၇၃ သန်း
၈.၈၈ သန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၂၄ ကုဋေ
၁.၀၈ ကုဋေ
၉.၇၃ သန်း
၈.၈၈ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁၂.၀၃ ကုဋေ
-၁၀.၈၇ ကုဋေ
-၁၀.၉၂ ကုဋေ
-၇.၅၇ ကုဋေ
Gain or loss from assets sale
-၂.၉၉ သိန်း
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ